摘要
目的分析应用经口内镜下肌切开术(POEM)治疗贲门失弛缓症的临床疗效。方法贲门失弛缓症患者164例,139例接受POEM(P组),25例接受开胸Heller手术治疗(H组)。回顾性分析手术相关资料,采用Eckhardt评分和胃食管反流病问卷(GerdQ)评分等指标比较两组的临床疗效和并发症发生情况。结果与H组比较,P组手术时间和禁食时间短(P<0.01),住院时间少(P<0.05)。两组患者均随访2年以上,结果显示,P组和H组术后1年Eckhardt评分均少于术前[(2.0±1.5)分vs.(5.6±1.2)分和(2.6±1.8)分vs.(5.9±1.0)分](P<0.01)。P组术后1年Eckhardt评分稍低于H组,GerdQ评分≥8分者的比例稍高于H组(P>0.05)。术后1年,P组有效率96.4%,高于H组的72.0%(P<0.01)。P组和H组手术相关并发症发生率分别为46.04%和36.00%(P>0.05)。结论与开胸Heller手术比较,POEM治疗贲门失弛缓症疗效好,手术费时少,安全性高。
Objective To analyze the clinical efficacy of peroral endoscopic myotomy(POEM) in the treatment of achalasia.Methods A total of 164 patients with achalasia was treated with POEM(group P,139 cases) or Heller open chest surgery(group H,25 cases).The operation-related data were analyzed retrospectively.With Eckhardt score and GerdQ score, the clinical efficacy and adverse responses were compared between the two groups.Results Compared with group H,group P had shorter surgery time and fasting time, and less hospital stay(P<0.01 or P<0.05).The patients of two groups were followed up for more than two years, which showed that Eckhardt scores of group P and group H were significantly less one year after operation than those before surgery [(2.0±1.5) points vs.(5.6±1.2) points and(2.6±1.8) points vs.(5.9±1.0) points](P<0.01).Compared with group H one year after operation, Eckhardt score of group P was slightly less and the proportion of the patients with GerdQ score≥8 points was slightly higher(P>0.05).The effectiveness rate of one year after operation was significantly higher in group P than that in group H(96.4% vs.72.0%)(P<0.01).The incidence rates of surgery-ralated adverse responses in groups of P and H were 46.04% and 36.00%,respectively(P>0.05).Conclusion Compared with Heller open chest surgery, POEM in the treatment of achalasia has the advantages of better efficacy, shorter surgery time, and higher safety.
作者
刘文婕
陶雨文
范志宁
LIU Wenjie;TAO Yuwen;FAN Zhining(Digestive Endoscopy Center,First Affiliated Hospital,Nanjing Medical University,Nanjing 210029,CHINA)
出处
《江苏医药》
CAS
2021年第7期719-722,共4页
Jiangsu Medical Journal